Forums before death by AOL, social media and spammers... "We can't have nice things"
|    sci.med.psychobiology    |    Dialog and news in psychiatry and psycho    |    4,734 messages    |
[   << oldest   |   < older   |   list   |   newer >   |   newest >>   ]
|    Message 3,058 of 4,734    |
|    Dr. AR Wingnutte, PhD to All    |
|    Decline in daily functioning related to     |
|    24 Oct 14 03:40:09    |
      From: drarwingnuttephd@gmail.com              Decline in daily functioning related to decreased brain activity in Alzheimer's                     Date:       August 12, 2014       Source:       Brigham and Women's Hospital              Summary:       Decline in daily functioning associated with Alzheimer's disease is related to       alterations in activity in certain regions of the brain, according to a study.       Impairment in instrumental activities of daily living -- or an inability to       perform high-level        daily activities such as calculating finances, remembering appointments and       medications, and driving -- is first seen when a person has mild cognitive       impairment, which can later progress to dementia due to Alzheimer's disease,       experts warn.                     Decline in daily functioning associated with Alzheimer's disease is related to       alterations in activity in certain regions of the brain, according to a study       published in the August 2014 issue of the Journal of Alzheimer's Disease.       Related Articles       Alzheimer's disease       Dementia with Lewy bodies       Dementia       Circadian rhythm       Clinical depression       Functional training       Impairment in instrumental activities of daily living -- or an inability to       perform high-level daily activities such as calculating finances, remembering       appointments and medications, and driving -- is first seen when a person has       mild cognitive        impairment, which can later progress to dementia due to Alzheimer's disease.       Deterioration in the ability to carry out daily activities has been associated       with changes in brain activity measured as use of energy (or metabolism of       sugar) with a nuclear        medicine scan called 18F-Flourodeoxy glucose (FDG) positron emission       tomography (PET).       To further investigate the relationship between instrumental activities of       daily living and brain activity (FDG metabolism), a team led by researchers       from Brigham and Women's Hospital (BWH) analyzed data from the Alzheimer's       Disease Neuroimaging        Initiative database, a multi-center study that BWH has been a part of for       nearly 10 years.       They looked at data from 104 clinically normal elderly participants, 203       participants with mild cognitive impairment, and 95 participants with mild       dementia due to Alzheimer's disease. The participants had a baseline PET scan       to determine brain activity        and underwent clinical assessments every 6 to 12 months for up to three years.       The participants' study partners (family members or friends who knew them       well) also completed questionnaires about the participants' daily living       activities.       The researchers found that decreased activity in frontal areas of the brain,       which are responsible for cognitive processing and decision making, and deep       temporal and parietal (back) areas of the brain, which are associated with       memory, were associated        with greater impairment of instrumental activities of daily living initially       and over time.       "Impairment in activities of daily living is a major source of burden for       Alzheimer's disease patients and caregivers alike," said Gad Marshall, MD, BWH       Center for Alzheimer Research and Treatment, assistant professor of Neurology       at Harvard Medical        School, senior study author. "Therefore, detecting these important deficits       early on prior to the dementia stage, along with a better understanding of how       they relate to changes in the brain, can lead to more effective design of       clinical trials that        focus on vital patient-centered outcomes. This in turn will ultimately lead to       better treatments prescribed to patients at the early stages of Alzheimer's       disease before they are robbed of their faculties and autonomy."       According to the National Institute on Aging, National Institutes of Health,       as many as five million people age 65 and older in the United States have       dementia due to Alzheimer's disease. As the rapid growth of the aging       population continues, the number        of those developing the disease is expected to increase significantly, with       the number of people with dementia due to Alzheimer's disease doubling for       every five-year interval beyond age 65.       Story Source:       The above story is based on materials provided by Brigham and Women's       Hospital. Note: Materials may be edited for content and length.       Journal Reference:       Gad Marshall et al. Regional Fluorodeoxyglucose Metabolism and Instrumental       Activities of Daily Living across the Alzheimer's Disease Spectrum. Journal of       Alzheimer's Disease, August 2014 DOI: 10.3233/JAD-131796       Cite This Page:       MLA APA Chicago       Brigham and Women's Hospital. "Decline in daily functioning related to       decreased brain activity in Alzheimer's." ScienceDaily. ScienceDaily, 12       August 2014. |
[   << oldest   |   < older   |   list   |   newer >   |   newest >>   ]
(c) 1994, bbs@darkrealms.ca